A beneficial role for IL-17A in DSS colitis was also demonstrated by Ogawa et al[33] who showed that administration of a IL-17 neutralizing antibody during acute DSS colitis resulted in aggravated disease with increased neutrophil infiltration. This evidence concerns the gene IL17A and colitis.